DOORDASH, INC. (DASH) Spending and interest coverage
- R&D / revenue · 12 months: Value 10.74%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 7.01%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 10.74% | Research and development expense / revenue. Period ending 2026-06-30. $1.71B ÷ $15.89B × 100 ≈ 10.74% |
| Stock-based compensation / revenue · 12 months | 7.01% | Share-based compensation / revenue. Period ending 2026-06-30. $1.11B ÷ $15.89B × 100 ≈ 7.01% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.71B USD | Research and Development Expense |
| Revenue | 15.89B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.11B USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 712.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.71B | $15.89B | $1.11B | $712.00M | (m) | 10.74% | 7.01% | (m) | (m) |
| 2026-03-31 | $1.52B | $14.72B | $1.05B | $719.00M | (m) | 10.35% | 7.11% | (m) | (m) |
| 2025-12-31 | $1.43B | $13.72B | $1.05B | $723.00M | (m) | 10.43% | 7.66% | (m) | (m) |
| 2025-09-30 | $1.31B | $12.63B | $1.05B | $693.00M | (m) | 10.36% | 8.28% | (m) | (m) |
| 2025-06-30 | $1.24B | $11.89B | $1.06B | $542.00M | (m) | 10.45% | 8.93% | (m) | (m) |
| 2025-03-31 | $1.20B | $11.24B | $1.08B | $178.00M | (m) | 10.63% | 9.63% | (m) | (m) |
| 2024-12-31 | $1.17B | $10.72B | $1.10B | $-38.00M | (m) | 10.89% | 10.25% | (m) | (m) |
| 2024-09-30 | $1.12B | $10.15B | $1.10B | $-244.00M | (m) | 11.07% | 10.81% | (m) | (m) |
| 2024-06-30 | $1.08B | $9.61B | $1.10B | $-459.00M | (m) | 11.29% | 11.46% | (m) | (m) |
| 2024-03-31 | $1.05B | $9.11B | $1.11B | $-469.00M | (m) | 11.53% | 12.18% | (m) | (m) |
| 2023-12-31 | $1.00B | $8.63B | $1.09B | $-579.00M | (m) | 11.62% | 12.60% | (m) | (m) |
| 2023-09-30 | $1.00B | $8.15B | $1.10B | $-860.00M | (m) | 12.27% | 13.48% | (m) | (m) |
| 2023-06-30 | $976.00M | $7.69B | $1.07B | $-1.06B | (m) | 12.70% | 13.92% | (m) | (m) |
| 2023-03-31 | $912.00M | $7.16B | $990.00M | $-1.12B | $3.00M | 12.73% | 13.82% | -374.00× | Reported |
| 2022-12-31 | $829.00M | $6.58B | $889.00M | $-1.12B | $2.00M | 12.59% | 13.50% | -562.00× | Reported |
| 2022-09-30 | $712.00M | $6.07B | $738.00M | $-908.00M | $2.00M | 11.74% | 12.17% | -454.00× | Reported |
| 2022-06-30 | $601.00M | $5.64B | $611.00M | $-700.00M | $2.00M | 10.66% | 10.84% | -350.00× | Reported |
| 2022-03-31 | $496.00M | $5.27B | $518.00M | $-526.00M | $2.00M | 9.42% | 9.83% | -263.00× | Reported |
| 2021-12-31 | $430.00M | $4.89B | $486.00M | $-452.00M | $14.00M | 8.80% | 9.94% | -32.29× | Reported |
| 2021-09-30 | $506.00M | $4.56B | $668.00M | $-603.00M | $23.00M | 11.10% | 14.66% | -26.22× | Reported |
| 2021-06-30 | $432.00M | $4.16B | $549.00M | $-538.00M | $32.00M | 10.38% | 13.19% | -16.81× | Reported |
| 2021-03-31 | $370.00M | $3.60B | $414.00M | $-412.00M | $40.00M | 10.27% | 11.50% | -10.30× | Reported |
| 2020-12-31 | $321.00M | $2.89B | $322.00M | $-436.00M | $32.00M | 11.12% | 11.16% | -13.63× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $107.00M | $885.00M | $18.00M | $-616.00M | $0.00 | 12.09% | 2.03% | (m) | Reported |
| 2018-12-31 | $51.00M | $291.00M | $24.00M | $-210.00M | $1.00M | 17.53% | 8.25% | -210.00× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.